Takeda Pharmaceutical Company Limited
Hedge Funds Holdings
Last updated:
Takeda Pharmaceutical Company Limited‘s stocks are currently a part of 217 hedge funds’ portfolios, which represents 3.22% of the total amount of its stocks outstanding. This makes up a total of 50.77M shares of Takeda Pharmaceutical Company Limited. Compared to the previous quarter, the number fell by -25.19% or -17.09M shares fewer. As for the holding position changes, 39.17% (85) of current hedge fund investors increased the number of shares held, 22.12% (48) of current holders sold a part of the shares held, and 6.45% (14) closed the holdings completely. 28 hedge funds are new holders of Takeda Pharmaceutical Company Limited stock in Q1 2023, it is 12.9% of total holders.
Hedge funds holding Takeda Pharmaceutical Company Limited (Q2 2018 – Q1 2023)
| Q2 2018 | 14 |
|---|---|
| Q3 2018 | 16 |
| Q4 2018 | 89 |
| Q1 2019 | 374 |
| Q2 2019 | 334 |
| Q3 2019 | 301 |
| Q4 2019 | 323 |
| Q1 2020 | 293 |
| Q2 2020 | 292 |
| Q3 2020 | 294 |
| Q4 2020 | 295 |
| Q1 2021 | 298 |
| Q2 2021 | 285 |
| Q3 2021 | 273 |
| Q4 2021 | 276 |
| Q1 2022 | 266 |
| Q2 2022 | 263 |
| Q3 2022 | 259 |
| Q4 2022 | 269 |
| Q1 2023 | 217 |
Hedge funds changes in Takeda Pharmaceutical Company Limited positions (Q2 2018 – Q1 2023)
| Q2 2018 | 4 | 4 | 3 | 1 | 2 |
|---|---|---|---|---|---|
| Q3 2018 | 2 | 7 | 4 | 0 | 3 |
| Q4 2018 | 80 | 1 | 6 | 7 | -5 |
| Q1 2019 | 296 | 59 | 13 | 9 | -3 |
| Q2 2019 | 50 | 92 | 115 | 82 | -5 |
| Q3 2019 | 27 | 102 | 95 | 60 | 17 |
| Q4 2019 | 61 | 84 | 102 | 35 | 41 |
| Q1 2020 | 35 | 85 | 98 | 61 | 14 |
| Q2 2020 | 41 | 73 | 98 | 40 | 40 |
| Q3 2020 | 36 | 90 | 87 | 32 | 49 |
| Q4 2020 | 47 | 82 | 96 | 41 | 29 |
| Q1 2021 | 53 | 105 | 68 | 48 | 24 |
| Q2 2021 | 28 | 92 | 96 | 42 | 27 |
| Q3 2021 | 29 | 85 | 88 | 38 | 33 |
| Q4 2021 | 56 | 63 | 103 | 51 | 3 |
| Q1 2022 | 42 | 93 | 66 | 47 | 18 |
| Q2 2022 | 40 | 88 | 84 | 43 | 8 |
| Q3 2022 | 35 | 95 | 68 | 32 | 29 |
| Q4 2022 | 56 | 70 | 97 | 40 | 6 |
| Q1 2023 | 28 | 85 | 48 | 14 | 42 |
Hedge funds changes in Takeda Pharmaceutical Company Limited stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 7,053,000 | 4,344,000 |
| Q1 2019 | 85,042,000 | 87,847,000 |
| Q2 2019 | 105,120,000 | 96,538,000 |
| Q3 2019 | 76,762,000 | 80,813,000 |
| Q4 2019 | 89,821,000 | 92,030,000 |
| Q1 2020 | 43,181,000 | 53,756,000 |
| Q2 2020 | 55,485,000 | 63,795,000 |
| Q3 2020 | 51,750,000 | 60,488,000 |
| Q4 2020 | 48,657,000 | 57,699,000 |
| Q1 2021 | 69,687,856 | 77,751,500 |
| Q2 2021 | 44,467,000 | 24,593,000 |
| Q3 2021 | 55,998,000 | 21,074,000 |
| Q4 2021 | 49,748,000 | 9,765,000 |
| Q1 2022 | 29,144,000 | 4,716,000 |
| Q2 2022 | 22,970,000 | 3,456,000 |
| Q3 2022 | 21,950,000 | 6,462,000 |
| Q4 2022 | 19,934,240 | 15,405,000 |
| Q1 2023 | 0 | 0 |